Burleson & Co’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $5.36K | Sell |
8,413
-295,505
| -97% | -$188K | ﹤0.01% | 294 |
|
|
2022
Q3 | $404K | Buy |
303,918
+43,769
| +17% | +$58.2K | 0.09% | 96 |
|
|
2022
Q2 | $578K | Buy |
260,149
+35,550
| +16% | +$79K | 0.13% | 86 |
|
|
2022
Q1 | $1.39M | Buy |
224,599
+8,490
| +4% | +$52.5K | 0.22% | 75 |
|
|
2021
Q4 | $2.73M | Buy |
216,109
+80,995
| +60% | +$1.02M | 0.4% | 47 |
|
|
2021
Q3 | $12.4M | Buy |
135,114
+3,984
| +3% | +$365K | 1.84% | 16 |
|
|
2021
Q2 | $6.95M | Buy |
131,130
+10,950
| +9% | +$580K | 1.01% | 25 |
|
|
2021
Q1 | $4.33M | Buy |
120,180
+78,803
| +190% | +$2.84M | 0.7% | 26 |
|
|
2020
Q4 | $1.15M | Sell |
41,377
-51,941
| -56% | -$1.44M | 0.2% | 75 |
|
|
2020
Q3 | $4.48M | Buy |
93,318
+39,060
| +72% | +$1.88M | 0.85% | 25 |
|
|
2020
Q2 | $2.39M | Buy |
54,258
+22,100
| +69% | +$975K | 0.52% | 44 |
|
|
2020
Q1 | $1.48M | Buy |
32,158
+23,880
| +288% | +$1.1M | 0.39% | 57 |
|
|
2019
Q4 | $470K | Buy |
+8,278
| New | +$470K | 0.13% | 97 |
|